𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Endemic african kaposi's sarcoma is not associated with immunodeficiency

✍ Scribed by Luc Kestens; Mads Melbye; Robert J. Biggar; Wim J. Stevens; Peter Piot; Aimé De Muynck; Henri Taelman; Marc De Feyter; L. Paluku; Paul L. Gigase

Publisher
John Wiley and Sons
Year
1985
Tongue
French
Weight
629 KB
Volume
36
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Twenty‐seven histologically confirmed Kaposi sarcoma (KS) patients resident in the Kivu Lake area of eastern Zaire were examined for immune competence. Only KS cases of the endemic African type have been observed in this high‐incidence area. The median duration of the symptoms was 6 years and ranged from 1 to 38 years. Forty‐one controls matched for age, sex and tribe and unrelated to the KS patients were selected from the community. Thirteen additional controls were first‐degree relatives of the KS patients. No evidence of immune suppression among KS patients was found and there were no significant differences in the immune status between KS patients and controls. Total lymphocytes, B and T cells, and OKT4 + and OKT8 + cells varied within the normal range. Grouping of the KS patients in categories according to duration and disease extent did not reveal significant differences in their immune status. The number of KS patients reacting positively in a skin test to 5 recall antigens and I mitogen was similar that of controls, except in the case of candidin, to which a higher number of KS patients were negative. The serum levels of immunoglobulins, complement factors and circulating immune complexes were comparable in KS patients and controls. Indicators of inflammatory processes [white blood cells (WBC), complement‐reactive protein (CRP)] were positive in 27% of the KS patients. The prevalence and mean titer of antibody against cytomegalovirus (CMV), Epstein‐Barr virus (EBV), hepatitis B virus (HBV) and syphilis were similar in KS patients and in controls.

📜 SIMILAR VOLUMES

Kaposi's sarcoma-associated herpesvirus
Kaposi's sarcoma-associated herpesvirus sequences in benign lymphoid proliferations not associated with human immunodeficiency virus
✍ Amy Chadburn; Ethel Cesarman; Roland G. Nador; Yi Fang Liu; Daniel M. Knowles 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 582 KB

## Background: Kaposi's sarcoma-associated herpesvirus (kshv) dna sequences have been identified in approximately 95% of kaposi's sarcoma (ks) lesions and primary effusion lymphomas (pels), suggesting a pathogenetic role for this virus in these lesions. however, kshv has also been identified in a v

HLA studies of endemic african kaposi's
HLA studies of endemic african kaposi's sarcoma patients and matched controls: No association with hla-DR5
✍ Mads Melbye; Luc Kestens; Paul L. Gigase; Robert J. Biggar; Geziena M. T. Schreu 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 351 KB

In the search for a genetic factor involved in the etiology of Kaposi's sarcoma, several studies have recently focused on a significantly increased HLA determinant, DRS, as well as a decreased DR3, among patients with both the classical and the AIDS-related form of Kaposi's sarcoma. To test the cons

Treatment with taxanes of refractory or
Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection
✍ Laurence Fardet; Pierre-Emmanuel Stoebner; Herve Bachelez; Vincent Descamps; Del 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

## Abstract ## BACKGROUND Kaposi sarcoma (KS) is an angioproliferative disease that may represent a difficult therapeutic challenge in disseminated stages. The efficacy of taxanes (paclitaxel and docetaxel), as agents with antiangiogenic properties, has been described previously in the treatment o

HHV8 a subtype is associated with rapidl
HHV8 a subtype is associated with rapidly evolving classic Kaposi's sarcoma
✍ Roberta Mancuso; Renato Biffi; Marilena Valli; Monica Bellinvia; Tourlaki Athana 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

## Abstract The link between human herpesvirus 8 (KSHV) and Kaposi's sarcoma (KS) has been proven, but many important aspects including risk factors, genetic predisposition to tumor development, transmission of KSHV, and the pathogenic potential of different genotypes remain to be elucidated. Possi

Diverse genotypes of Kaposi's sarcoma as
Diverse genotypes of Kaposi's sarcoma associated herpesvirus (KSHV) identified in infant blood infections in African childhood-KS and HIV/AIDS endemic region
✍ F.C. Kasolo; J. Spinks; H. Bima; M. Bates; U.A. Gompels 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB

## Abstract Kaposi's sarcoma‐associated herpesvirus (KSHV or HHV‐8) has been associated with several neoplasias, including childhood endemic Kaposi's sarcoma (KS). It is possible that strain genotypes could contribute to the differences in regional presentation (mainly sub‐Saharan Africa), childhoo